|
|
|
| ||||
Last Loaded on Web: Monday, April 01, 2013
Prous Science Daily EssentialsTM, produced by Prous Science Publishers, is a clear, concise and flexible database that provides up-to-date drug R&D information. More than 25 late-breaking news items including information from ongoing congresses and conferences are posted in the current file (File 458) each business day. It offers users practical and accurate information including chemical structures, data tables and other images for day-to-day decisions in drug R&D and marketing. A searchable archive (File 459) gives access to more than 25,000 news items dating back to early 1996. These files are a valuable source of up-to-date information for professionals in research, development, management, marketing, licensing, and new business development within the pharmaceutical industry and for all those interested in this industry's activities.
USE FILES 458 AND 459to keep up-to-date on new developments in drug R&D throughout the world. USE /NA, NA= or /SY, SY=to search for a drug name: S ERYLOSIDE/NAUSE the S operatorto ensure the terms appear in the same paragraph: S THROMBIN(S)AGGREGATION?/TXUSE MAP NA or SYto save associated drug names for further searching: USE FORMAT 19to display full record with image. /p> |
Prous Science Daily Essentials database provides the following information:
Principal sources for the news items published in Prous Science Daily Essentials are the current biomedical literature, patent literature, congresses, company communications, and Internet monitoring. The most recent patent literature is from 11 different sources, reflecting research activity throughout the world. The database includes the information from 1,500 journals, 300 congresses and meetings, company communications and Internet Monitoring. The information describes the activity of more than 2,500 companies, research institutes and universities.
| ACRONYM | CATEGORY NAME |
|---|---|
| BIOBUS | Biosciences and Biotechnology Industry |
| DRUGDEV | Drug Development Pipeline |
| DRUGDIR | Drug Directories |
| DRUGECON | Pharmacoeconomics |
| PHARM | Pharmacology |
| PHARMIND | Pharmaceutical Industry News |
| PHARMR | Pharmacology + RINGDOC-Files |
| PHARMREG | Pharmaceutical Regulation |
| PROUS | Prous Science Publishers Files |
|
Prous Science Daily Essentials is provided by Prous Science Publishers. Questions concerning the file content should be directed to: P.O. Box 540 Barcelona, 08080 Spain
|
For Dialog's Redistribution and Archive Policy, enter HELP ERA online. The following terms and conditions also apply. (c)2000 Prous Science, S.A. All rights reserved. No part of this electronic database may be reproduced, abstracted, or transmitted in any form or by any means --electronic, mechanical, photocopying, recording, or otherwise--without the express written permission of the publisher, Prous Science, S.A. While great care has been taken in the preparation of this database, and the publisher has made a reasonable effort to supply complete and accurate information, it does not assume any liability for errors or omissions. Prous Science, S.A. makes no warranties, expressed or implied, with respect to the accuracy, quality, validity, or completeness of this database or the information therein or its merchantability or fitness for a particular purpose.
| DIALOG(R)File 458:Daily Essentials | |
| (c) 2000 Prouse Science. All rts. reserv. | |
| 00032686 | |
| /TI | ERYLOSIN F: A NEW THROMBIN RECEPTOR ANTAGONIST PRODUCED BY A MARINE SPONGE |
| JN= | Daily Essentials |
| PD=,PY= | May 17, 2000 (20000517) |
| DT= | DOCUMENT TYPE: Current Literature |
| /ST,ST= | DEVELOPMENT STATUS: New Compound |
| LA= | LANGUAGE: English |
| RT= | RECORD TYPE: Fulltext; Image |
| /TX | A novel penasterol disaccharide designated eryloside F has been |
| discovered during a screening for thrombin receptor antagonists at Glaxo | |
| Wellcome and the Harbor Branch Oceanographic Institution. Isolated from an | |
| extract of the marine sponge Erylus formosus, the compound is closely | |
| related to formoside and acts as a potent and relatively selective thrombin | |
| receptor antagonist and antiplatelet agent, as demonstrated by IC50 values | |
| for inhibition of SFLLRN (thrombin receptor-activating peptide)- and | |
| U-46619-induced human platelet aggregation of 0.3 mcg/ml and 1.7 mcg/ml, | |
| respectively. It is also reported to possess low toxicity in HepG2 cells | |
| (Stead, P. et al. Bioorg Med Chem Lett 2000, 10(7): 661). | |
| /CO,CO= | NAMED COMPANIES: Glaxo Wellcome; Harbor Branch Oceanographic Institution |
| /NA,NA=,/SY,SY=,AA= | NAMED DRUGS: Eryloside F [288492] |
| |
| /TC,TC= | THERAPEUTIC CLASS: Blood Coagulation, Agents Affecting; Antiplatelet |
| Therapy |
| SEARCH SUFFIX |
DISPLAY CODE |
FIELD NAME |
INDEXING |
SELECT EXAMPLES |
|---|---|---|---|---|
| None | None | All Basic Index Fields | Word | S LOW(W)TOXICITY |
| /CO | CO | Company Name1 | Word | S GLAXO(W)WELCOME/CO |
| /NA | NA | Drug Name1 | Word | S ERYLOSIDE(W)F/NA |
| /ST | ST | Development Status1 | Word | S NEW(W)COMPOUND/ST |
| /SY | SY | Drug Name1 | Word | S ERYLOSIDE(W)F/SY |
| /TC | TC | Therapeutic Class Text1,2 | Word & Phrase |
S BLOOD(W)COAGULATION/TC S ANTIPLATELET THERAPY/TC |
| /TI | TI | Title | Word | S THROMBIN(W)RECEPTOR/TI |
| /TX | TX | Text | Word | S THROMBIN(S)AGENT/TX |
1 Searchable in the Basic Index and in the Additional Indexes.
2 Also searchable using /DE, /DF.
| SEARCH PREFIX |
DISPLAY CODE |
FIELD NAME |
INDEXING |
SELECT EXAMPLES |
|---|---|---|---|---|
| AA= | AA | Prous Entry Number3 | Phrase | S AA=288492 |
| None | AZ | DIALOG Accession Number | ||
| CO= | CO | Company Name1 | Phrase | S CO=HARBOR BRANCH? |
| DT= | DT | Document Type | Phrase | S DT=CURRENT LITERATURE |
| None | IM | Image | ||
| JN= | JN | Journal Name | Phrase | S JN=DAILY ESSENTIALS |
| LA= | LA | Language4 | Phrase | S LA=ENGLISH |
| NA= | NA | Drug Name1 | Phrase | S NA=ERYLOSIDE F |
| PD= | PD | Publication Date | Phrase | S PD=20000517 |
| PN= | PN | Patent Number | Phrase | S PN=US 6051582 |
| PY= | PY | Publication Year | Phrase | S PY=2000 |
| RT= | RT | Record Type5 | Phrase | S RT=FULLTEXT |
| ST= | ST | Development Status1 | Phrase | S ST=NEW COMPOUND |
| SY= | SY | Drug Name1 | Phrase | S SY=ERYLOSIDE F |
| TC= | TC | Therapeutic Class Text1,2 | Phrase | S TC=BLOOD COAGULATION |
| UC= | None | Update Code - Changed Records | Phrase | S UC=9999 |
| UD= | None | Update | Phrase | S UD=9999 |
3 This field will appear in a record only if a drug name is present in the record. This number is not unique as record may discuss multiple drugs each with their own AA.
| SUFFIX | FIELD NAME | EXAMPLES |
|---|---|---|
| /ENG | English-Language Articles4 | S S3/ENG |
| /FULLTEXT | Full-Text Records5 | S S2/FULLTEXT |
| /IMAGE | Image | S S1/IMAGE |
| /LONG | Word Count of 1,000 Words or More | S S4/LONG |
| /SHORT | Word Count of Less than 1,000 Words | S S5/SHORT |
| /YYYY | Publication Year | S S6/2000 |
| SORTABLE FIELDS | EXAMPLES |
|---|---|
| CO, NA, PD, PY, SY, TI | SORT S2/ALL/TI SORT S1/ALL/NA/D SORT S3/ALL/PY/D |
| RANK FIELDS | EXAMPLES |
|---|---|
| All phrase- and numeric-indexed fields in the Additional Indexes can be ranked. Other RANK codes include: TC | RANK TC S2 RANK NA S3 RANK SY S1 |
| MAP FIELDS | EXAMPLES |
|---|---|
| AA, CO, NA, SY | MAP CO TEMP S2 MAP NA TEMP S3 |
| Display codes listed in the Search Options tables can be used to customize output | TYPE S4/TI,TX/1-5 PRINT S5/CO,PN/ALL DISPLAY S3/NA,TC/2-3 |
| NO. |
DIALOGWEB FORMAT |
RECORD CONTENT |
|---|---|---|
| 1 | -- | DIALOG Accession Number |
| 2 | Medium | Bibliographic Citation |
| 3 | Short | Title and Drug Name |
| 4 | -- | Full Record with Tagged Fields |
| 5 | -- | Full Record |
| 6 | Free | Title, Publication Date, and Publication Year |
| 7 | -- | Bibliographic Citation and Text |
| 8 | -- | Title, Indexing, Publication Date and Publication Year |
| 9 | Long | Full Record |
| 19 | Full | Full Record plus Image |
| K | -- | KWIC (Key Word In Context) displays a window of text; may be used alone or with other formats |
| FIELD NAME | EXAMPLES | ||
|---|---|---|---|
| If the accession number of a specific record is known, it can be used to display the record directly. | TYPE 00085603/9 PRINT 00095905/9 DISPLAY 00095905/9 |
||
Rates For File: Prous Science Daily Essentials - Daily[458]
Cost per DialUnit: $9.18
Cost per minute: $3.70
Rank Elements $0.00
Format Types Prints
1 $0.00 $0.00
2 $7.00 $7.00
3 $4.00 $4.00
4 $13.00 $13.00
5 $13.00 $13.00
6 $0.00 $0.00
7 $13.00 $13.00
8 $7.00 $7.00
9 $13.00 $13.00
19 $15.00 $15.00
KWIC95 $4.00 NA
KWIC96 $4.00 NA
REDIST/COPY Multiplier Table:
Range Multiplier
1-2 1.00
3-25 1.50
26-100 3.00
101-200 4.00
201-500 6.00
501-1000 8.00
1001 or more 10.00
ARCHIVE Multiplier Table:
Range Multiplier
1-25 1.50
26-200 3.00
201-500 6.00
501-1000 8.00
1001 or more 10.00
Rates For File: Prous Science Daily Essentials - Weekly[459]
Cost per DialUnit: $9.18
Cost per minute: $3.70
Rank Elements $0.00
Format Types Prints
1 $0.00 $0.00
2 $7.00 $7.00
3 $4.00 $4.00
4 $13.00 $13.00
5 $13.00 $13.00
6 $0.00 $0.00
7 $13.00 $13.00
8 $7.00 $7.00
9 $13.00 $13.00
19 $15.00 $15.00
KWIC95 $4.00 NA
KWIC96 $4.00 NA
REDIST/COPY Multiplier Table:
Range Multiplier
1-2 1.00
3-25 1.50
26-100 3.00
101-200 4.00
201-500 6.00
501-1000 8.00
1001 or more 10.00
ARCHIVE Multiplier Table:
Range Multiplier
1-25 1.50
26-200 3.00
201-500 6.00
501-1000 8.00
1001 or more 10.00
